Article and Video CATEGORIES

Cancer Journey

Search By

Ramy Sedhom, MD, is a Medical Oncology Fellow at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland.

He is interested in Supportive and Palliative Care for patients across the cancer continuum - from a clinical, research, and policy perspective. Following his oncology training, he will be pursuing a clinical fellowship in Hospice and Palliative Care.

The Role of Immunotherapy in Metastatic Bladder Cancer
Author
Ramy Sedhom, MD, GRACE Guest Faculty
Image

GRACE is excited to bring you new information in our Bladder Cancer Program, hosted by Ramy Sedhom, MD.

For this video, Dr. Ramy Sedhom introduces us to Dr. Matthew Galsky with the Tisch Cancer Institute and Icahn School of Medicine at Mt. Sinai in New York.  In this video, Drs. Sedhom and Galsky discuss the role of immunotherapy in metastatic bladder cancer. 


If you have questions or comments, please feel free to join the conversation at https://cancergrace.org/forums/bladder-cancer.

 

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora